@chrismasterjohn : This is a move in the right direction. However, the FDA must also reveal, repudiate, and reject the “test negative” scam of a trial design. ✅ Total mortality must be the prized endpoint. ✅ Total morbidity of the disease category must be prized above testing negative for a • TwiCopy

Chris Masterjohn

@chrismasterjohn

+ Follow

PhD in Nutritional Sciences. Adding nuance to health science, using biochemistry to find your individuality.

ID: 83625835

linkhttp://chrismasterjohn-phd.com calendar_today19-10-2009 15:39:51

47,47K Tweet

65,65K Followers

199 Following

Chris Masterjohn

@chrismasterjohn

2 months ago

This is a move in the right direction. However, the FDA must also reveal, repudiate, and reject the “test negative” scam of a trial design. ✅ Total mortality must be the prized endpoint. ✅ Total morbidity of the disease category must be prized above testing negative for a

thumb_up_off_alt73

chat_bubble_outline1

repeat15

shareShare